Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiple Sclerosis with Onset Younger Than 10 Years in Turkey.
Öztürk Z, Yılmaz Ü, Konuşkan B, Gücüyener K, Demir E, Anlar B; Turkish Pediatric Multiple Sclerosis Study Group. Öztürk Z, et al. Among authors: anlar b. Neuropediatrics. 2018 Feb;49(1):51-58. doi: 10.1055/s-0037-1608776. Epub 2017 Nov 28. Neuropediatrics. 2018. PMID: 29183093
Cognitive functions in pediatric multiple sclerosis: 2-years follow-up.
Öztürk Z, Gücüyener K, Soysal Ş, Konuşkan GD, Konuşkan B, Dikmen AU, Anlar B. Öztürk Z, et al. Among authors: anlar b. Neurol Res. 2020 Feb;42(2):159-163. doi: 10.1080/01616412.2019.1710417. Epub 2020 Jan 8. Neurol Res. 2020. PMID: 31913090
Re-examining the characteristics of pediatric multiple sclerosis in the era of antibody-associated demyelinating syndromes.
Yılmaz Ü, Gücüyener K, Yavuz M, Öncel İ, Canpolat M, Saltık S, Ünver O, Çıtak Kurt AN, Tosun A, Yılmaz S, Özgör B, Erol İ, Öztoprak Ü, Elitez DA, Direk MÇ, Bodur M, Teber S, Anlar B; Turkish Pediatric Multiple Sclerosis Study Group. Yılmaz Ü, et al. Among authors: anlar b. Eur J Paediatr Neurol. 2022 Nov;41:8-18. doi: 10.1016/j.ejpn.2022.08.006. Epub 2022 Sep 1. Eur J Paediatr Neurol. 2022. PMID: 36137476
Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial.
Chitnis T, Banwell B, Kappos L, Arnold DL, Gücüyener K, Deiva K, Skripchenko N, Cui LY, Saubadu S, Hu W, Benamor M, Le-Halpere A, Truffinet P, Tardieu M; TERIKIDS Investigators. Chitnis T, et al. Lancet Neurol. 2021 Dec;20(12):1001-1011. doi: 10.1016/S1474-4422(21)00364-1. Lancet Neurol. 2021. PMID: 34800398 Clinical Trial.
Childhood optic neuritis: the pediatric neurologist's perspective.
Cakmakli G, Kurne A, Güven A, Serdaroğlu A, Topaloğlu H, Teber S, Anlar B. Cakmakli G, et al. Among authors: anlar b. Eur J Paediatr Neurol. 2009 Sep;13(5):452-7. doi: 10.1016/j.ejpn.2008.09.003. Epub 2008 Oct 21. Eur J Paediatr Neurol. 2009. PMID: 18945627
226 results